McKesson Cash Flow Statement
NYSE: MCKHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
McKesson free cash flow
In fiscal 2026, McKesson generated $6.16 billion of operating cash flow and spent $436.0 million on capital expenditures. That left free cash flow of $5.72 billion, a free-cash-flow margin of 1.4% of revenue. Free cash flow was up 3.1% from the prior year's $5.55 billion.
McKesson returned $5.13 billion to shareholders: $381.0 million in dividends and $4.75 billion in share repurchases, equal to 90% of free cash flow. Free cash flow covered dividend payments 15.0 times.
Summary generated from market data by MetaCap's automated system. Methodology
McKesson cash flow statement (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 | FY 20172017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 5.10B | 3.48B | 3.16B | 3.72B | 1.29B | -4.34B | 1.12B | 255.00M | 297.00M | 5.15B |
| Net Income growth (YoY) | +46.48% | +10.16% | -15.10% | +189.20% | — | -487.50% | +339.22% | -14.14% | -94.24% | +123.07% |
| Depreciation & Amortization | 287.00M | 272.00M | 279.00M | 272.00M | 312.00M | 344.00M | 335.00M | 317.00M | 951.00M | 910.00M |
| Stock-Based Compensation | 247.00M | 226.00M | 182.00M | 162.00M | 161.00M | 151.00M | 119.00M | 95.00M | 69.00M | 115.00M |
| Change in Working Capital | 1.24B | 2.10B | 339.00M | 1.45B | -210.00M | 136.00M | 1.08B | 641.00M | 845.00M | 1.54B |
| Operating Cash Flow | 6.16B | 6.08B | 4.31B | 5.16B | 4.43B | 4.54B | 4.37B | 4.04B | 4.34B | 4.74B |
| Capital Expenditures | -436.00M | -537.00M | -431.00M | -390.00M | -388.00M | -451.00M | -362.00M | -426.00M | -405.00M | -404.00M |
| Investing Cash Flow | -3.43B | -733.00M | -1.07B | -542.00M | -89.00M | -415.00M | -579.00M | -1.38B | -2.99B | -3.27B |
| Dividends Paid | -381.00M | -345.00M | -314.00M | -292.00M | -277.00M | -276.00M | -294.00M | -292.00M | -262.00M | -253.00M |
| Share Repurchases | -4.75B | -3.15B | -3.02B | -3.64B | -3.52B | -742.00M | -1.93B | -1.64B | -1.71B | -2.31B |
| Debt Issued | 1.99B | 498.00M | 991.00M | 997.00M | 498.00M | 500.00M | 0 | 1.10B | 1.52B | 1.82B |
| Debt Repaid | -1.21B | -519.00M | -288.00M | -1.27B | -1.65B | -1.04B | -298.00M | -1.11B | -2.29B | -1.60B |
| Financing Cash Flow | -4.63B | -3.96B | -3.34B | -4.37B | -6.32B | -1.69B | -2.73B | -2.23B | -3.08B | -2.07B |
| Net Change in Cash | -1.89B | 1.37B | -94.00M | 744.00M | -2.46B | 2.37B | 1.04B | 309.00M | -1.58B | -738.00M |
| Free Cash Flow | 5.72B | 5.55B | 3.88B | 4.77B | 4.05B | 4.09B | 4.01B | 3.61B | 3.94B | 4.34B |
This table shows 10 annual periods of McKesson's cash flow statement, from FY 2026 back to FY 2017, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MCK's reporting calendar. What is a cash flow statement?